Does structural racism impact receipt of NCCN guideline-concordant breast cancer treatment? Maya LubarskyAlexandra E HernandezNeha Goel Epidemiology 29 May 2024
Surgical marker navigation system in breast conserving surgery and excision of non-palpable lesions: first Spanish single-center experience Ángela Santana ValencianoSonia Rivas FidalgoJosé María Fernández Cebrián Research 28 May 2024
Clinical breast exam contribution to breast cancer diagnosis in BRCA mutation carriers vs. average to intermediate risk women Tehillah S. MenesDouglas ZippelDana Madorsky Feldman Research Open access 26 May 2024
Clinical benefit of post-trastuzumab deruxtecan treatment in patients with HER 2-positive unresectable or metastatic breast cancer: A single-institution retrospective observational study Ayaka IsogaiKazuki NozawaHiroji Iwata Clinical trial 26 May 2024
The Ki67 dilemma: investigating prognostic cut-offs and reproducibility for automated Ki67 scoring in breast cancer Emma RewcastleIvar SkalandEmiel A. M. Janssen Research Open access 26 May 2024
Measuring serum oestrogen levels in breast cancer survivors using vaginal oestrogens: a systematic review Antonia PearsonJill ChenBelinda E. Kiely Review Open access 23 May 2024
Pathomic model based on histopathological features and machine learning to predict IDO1 status and its association with breast cancer prognosis Xiaohua ZhuoHailong DengXiaoming Qiu Research Open access 23 May 2024
Changes in expression of breast cancer tumor biomarkers between primary tumors and corresponding metastatic sites: common patterns and relationships with survival Lara SchwiegerLauren M. PostlewaitXiaoxian Li Research 23 May 2024
Assessment of efficacy and safety of dose-dense doxorubicin and cyclophosphamide (ddAC) in combination with immunotherapy in early-stage triple-negative breast cancer Olivia WhiteSusan DentHeather N. Moore Research Open access 21 May 2024
Prognostic significance and value of further classification of lymphovascular invasion in invasive breast cancer: a retrospective observational study Yuyang ZhangHuali WangHongjiang Wang Research Open access 21 May 2024
Long-term outcomes of neoadjuvant trastuzumab emtansine + pertuzumab (T-DM1 + P) and docetaxel + carboplatin + trastuzumab + pertuzumab (TCbHP) for HER2-positive primary breast cancer: results of the randomized phase 2 JBCRG20 study (Neo-peaks) Toshimi TakanoNorikazu MasudaMasakazu Toi Clinical trial Open access 20 May 2024
Impact of environmental temperature on the survival outcomes of breast cancer: A SEER-based study Ashish GuptaArya Mariam RoyShipra Gandhi Research Open access 20 May 2024
Intraoperative spectroscopic evaluation of sentinel lymph nodes in breast cancer surgery Surekha BarkurRadu A. BoitorIoan Notingher Research Open access 20 May 2024
Use of beta-blockers in patients with ductal carcinoma in situ and risk of invasive breast cancer recurrence: a Swedish retrospective cohort study Carina StrellDaniel Robert SmithAglaia Schiza Research Open access 19 May 2024
Development and application of a weighted change score to evaluate interventions for vasomotor symptoms in patients with breast cancer using regression trees: a cohort study Katherine Marie ColeSharon McGeeKhaled El Emam Research Open access 19 May 2024
Coping with modesty during radiotherapy for breast cancer: a multicentric study Luca BoldriniLoredana DinapoliMaria Antonietta Gambacorta Research 18 May 2024
BE-WEL trial (breast: evaluation of weight and exercise for lymphoedema) testing weight control and exercise programmes for women with breast cancer related lymphoedema: a feasibility trial Michelle HarvieKaren LivingstoneNigel Bundred Research Open access 17 May 2024
Alteration of PD-L1 (SP142) status after neoadjuvant chemotherapy and its clinical significance in triple-negative breast cancer Ji Won WooEun Kyung HanSo Yeon Park Research Open access 16 May 2024
Combined transcriptome and proteome analysis reveals MSN and ARFIP2 as biomarkers for trastuzumab resistance of breast cancer Xiao ShiYuan ShengXinxin Si Research 15 May 2024
Racial differences in familiarity, interest, and use of integrative medicine among patients with breast cancer Jincong Q. FreemanJori B. SheadeRita Nanda Research Open access 15 May 2024
Measuring cfDNA integrity as a biomarker for predicting neoadjuvant chemotherapy response in breast cancer patients: a pilot study Camila GiroAlayne M. T. D. YamadaAuro del Giglio Original Laboratory Investigation 14 May 2024
An exploratory clinical trial of preoperative non-invasive localization before breast-conserving surgery using augmented reality technology Minah LeeJoohyun WooJun Woo Lee Preclinical study Open access 14 May 2024
The emerging predictive and prognostic role of HER2 in HER2-negative early breast cancer: a retrospective study Matilde CorianòChiara TommasiNicolò Matteo Luca Battisti Research 14 May 2024
Predictive analysis of breast cancer response to neoadjuvant chemotherapy through plasma metabolomics Miki YamadaHiromitsu JinnoMasahiro Sugimoto Research 13 May 2024
Characterizing “collateral damage” in men and women with metastatic breast cancer (mBC) from diverse racial and ethnic backgrounds in New York City Shoshana M. RosenbergCaroline ZengLaura C. Pinheiro Research 13 May 2024
Ductal carcinoma in situ and cause-specific mortality among younger and older postmenopausal women: the Women’s Health Initiative Kathy PanRebecca A. NelsonLaura Kruper Epidemiology 11 May 2024
Retraction Note: A83-01 inhibits TGF-β-induced upregulation of Wnt3 and epithelial to mesenchymal transition in HER2-overexpressing breast cancer cells Yanyuan WuTrinh TranJaydutt V. Vadgama Retraction Note 10 May 2024
Current axillary management of patients with early breast cancer and low-volume nodal disease undergoing primary surgery: results of a United Kingdom national practice survey K. FairhurstS. A. McIntoshOur Citable Collaborators Preclinical study Open access 10 May 2024
Do we need reshape rTNM staging system for ipsilateral breast tumor recurrence of breast cancer? A population-based, propensity score matched cohort study Shuwei ZhangHoupu YangShu Wang Research 10 May 2024
Long-term prospective outcome data using EndoPredict as risk stratification and chemotherapy decision biomarker in hormone receptor-positive, HER2-negative early breast cancer Evelyn KleinMarion KiechleJohannes Ettl Research Open access 09 May 2024
Left ventricular global longitudinal strain is worse in BRCA mutation positive breast cancer patients prior to cancer treatment and premature menopause Billy LinAlexis LeVeeChrisandra Shufelt Research 08 May 2024
Residual cancer burden in two-stage nipple sparing mastectomy after first stage lumpectomy and devascularization of the nipple areolar complex Candice N. ThompsonJulia ChandlerIrene Wapnir Research 07 May 2024
Impact of exercise on chemotherapy-induced peripheral neuropathy in survivors with post-treatment primary breast cancer Kirin SaintDavid NemirovskyTing Bao Research 07 May 2024
Effectiveness of gonadotropin-releasing hormone agonists for ovarian function suppression in premenopausal patients with hormone receptor-positive breast cancer: a retrospective single-center real-world study Yifei ChenRuyan ZhangGuohong Song Research Open access 06 May 2024
Clinical and molecular predictors of very late recurrence in oestrogen receptor-positive breast cancer patients Juliet RichmanGene SchusterMitch Dowsett Research Open access 06 May 2024
Correction: Performance of a novel spectroscopy-based tool for adjuvant therapy decision-making in hormone receptor-positive breast cancer: a validation study R Charles CoombesChristina AngelouCarlo Palmieri Correction Open access 05 May 2024
Correction: Is the CTS5 a helpful decision-making tool in the extended adjuvant therapy setting? Kerstin WimmerDominik HlauschekFlorian Fitzal Correction Open access 05 May 2024
Multi-omics portrait of ductal carcinoma in situ in young women Ruoxi HongBoyang CaoKang Shao Original Laboratory Investigation 05 May 2024
Treatment patterns and clinical outcomes in patients with metastatic triple-negative breast cancer: a large-scale data analysis using the Japanese claims database Takayuki KimuraTomoko TakamiShigehira Saji Epidemiology Open access 05 May 2024
Disparities in PI3K/mTOR inhibitor use, toxicities, and outcomes among patients with metastatic breast cancer Claire SatheMelissa K. AccordinoDawn L. Hershman Brief Report 04 May 2024
Everolimus plus endocrine therapy beyond CDK4/6 inhibitors progression for HR+ /HER2− advanced breast cancer: a real-world evidence cohort Rodrigo Sánchez-BayonaAlfonso Lopez de SaMiguel Martin Research 04 May 2024
Tumor-infiltrating lymphocytes as a predictor of axillary and primary tumor pathological response after neoadjuvant chemotherapy in patients with breast cancer: a retrospective cohort study Kian ChinAmalia H. LandénRoger Olofsson Bagge Clinical trial Open access 04 May 2024
Use of ultrasound and MRI to stage the axilla for breast cancer before and after neoadjuvant chemotherapy prior to targeted sentinel lymphadenectomy Danielle BrabenderApril BallardStephen F. Sener Research Open access 03 May 2024
Racialized economic segregation and inequities in treatment initiation and survival among patients with metastatic breast cancer Harlan PittellGregory S. CalipJenny S. Guadamuz Research Open access 03 May 2024
Exploring the epigenetic profile of ID4 in breast cancer: bioinformatic insights into methylation patterns and chromatin accessibility dynamics Daniela NasifSergio LauritoMaría Teresita Branham Research 03 May 2024
Correction: Five-year survival prognosis of young, middle-aged, and elderly adult female invasive breast cancer patients by clinical and lifestyle characteristics Yu-Tung TengYong Alison WangJason J. Liu Correction Open access 02 May 2024
Ten-year trend analysis of breast cancer, oncoplastic, and reconstructive breast surgery in a single institution (2010–2019), what has not changed? A. MoradK. JohnsonJ. Harvey Research 30 April 2024
Risk of first recurrence after treatment in a population-based cohort of young women with breast cancer Robin SchaffarSimone BenhamouElisabetta Rapiti Research Open access 30 April 2024
Circulating microRNAs and therapy-associated cardiac events in HER2-positive breast cancer patients: an exploratory analysis from NeoALTTO S. PizzamiglioC. M. CiniselliS. Di Cosimo Clinical trial Open access 30 April 2024
Clinico–pathologic factors and survival of patients with breast cancer diagnosed with de novo brain metastasis: a national cancer database analysis Ali HijaziMohamed MohannaZeina Nahleh Research Open access 29 April 2024
